Home › Stocks › NLSP

NLSP — NLS PHARMACEUTICS LTD

Reported value held$1.23M
Funds holding (latest)16
Sector—

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

NLSP (NLS PHARMACEUTICS LTD) is tracked on HoldingsHub across five years of quarterly 13F filings. 16 funds have reported positions historically, with the sum of their latest reported stakes valued at $1.23M. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.

Major shareholders of NLS PHARMACEUTICS LTD (NLSP) include ARMISTICE CAPITAL, LLC, BVF INC/IL, J. Goldman & Co LP, ranked by reported 13F value among the 16 institutional holders on this page.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2025 3 143.75K $263.06K -9.4%
Q2 2025 4 161.20K $467.49K -6.3%
Q1 2025 2 169.41K $260.90K +11.5%
Q4 2024 2 151.97K $320.65K +2.4%
Q3 2024 2 148.40K $752.36K -97.5%
Q2 2024 9 8.53M $1.85M +1.2%
Q1 2024 7 8.16M $1.48M +2.9%
Q4 2023 5 5.83M $3.44M -0.1%

Over the 8 quarters shown, institutional share counts decreased 98% in aggregate (Q4 2023 → Q3 2025); the largest single-quarter swing was Q3 2024 (-97.5%).

Top Institutional Holders (Q3 2025) — 3 funds

FundSharesValuePortfolio WeightChange
BVF INC/IL 143.68K $262.93K 0.01% Hold
UBS Group AG 38 $70 0.00% Reduce
CoreCap Advisors, LLC 36 $66 0.00% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2025 — 4 funds

FundSharesValuePortfolio WeightChange
BVF INC/IL 143.68K $416.66K 0.01% Hold
UBS Group AG 14.98K $43.45K 0.00% Reduce
Morgan Stanley 2.51K $7.28K 0.00% New
CoreCap Advisors, LLC 36 $104 0.00% New

Q1 2025 — 2 funds

FundSharesValuePortfolio WeightChange
BVF INC/IL 143.68K $221.26K 0.01% Hold
UBS Group AG 25.74K $39.63K 0.00% Add

Q4 2024 — 2 funds

FundSharesValuePortfolio WeightChange
BVF INC/IL 143.68K $303.16K 0.01% Hold
UBS Group AG 8.29K $17.50K 0.00% Add

Q3 2024 — 2 funds

FundSharesValuePortfolio WeightChange
BVF INC/IL 143.68K $728.44K 0.02% Reduce
UBS Group AG 4.72K $23.93K 0.00% Reduce

Q2 2024 — 9 funds

FundSharesValuePortfolio WeightChange
BVF INC/IL 5.75M $1.25M 0.04% Hold
ARMISTICE CAPITAL, LLC 2.31M $501.26K 0.01% Add
UBS Group AG 235.72K $51.15K 0.00% New
Citadel Advisors 136.27K $29.56K 0.00% Add
JANE STREET GROUP, LLC 43.67K $9.47K 0.00% New
Renaissance Technologies 21.78K $4.72K 0.00% Reduce
Geode Capital Management 14.36K $3.12K 0.00% Hold
HRT FINANCIAL LP 16.83K $3.00K 0.00% New
Bank of America Corp 90 $19 0.00% Hold

New Positions (latest)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 16 funds)

FundQ3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
BVF INC/IL 143.68K 143.68K 143.68K 143.68K 143.68K 5.75M 5.75M 5.75M 5.75M — — — — — — — — —
UBS Group AG 38 14.98K 25.74K 8.29K 4.72K 235.72K — — — 3.41K — 9.84K — 15.25K 10.58K 12.77K 62.47K —
CoreCap Advisors, LLC 36 36 — — — — — — — — — — — — — — — —
ARMISTICE CAPITAL, LLC — — — — — 2.31M 2.17M — — — — — — — — — — —
J. Goldman & Co LP — — — — — — — — 254.60K — — — — — — — — —
Affinity Asset Advisors, LLC — — — — — — — — 200.46K — — — — — — — — —
Renaissance Technologies — — — — — 21.78K 179.58K 12.68K 21.10K 54.70K 32.10K 20.20K 25.80K 20.00K 21.70K 10.80K — 42.00K
Wells Fargo & Co — — — — — — — 56.55K 56.55K — — — — — — — — —
Citadel Advisors — — — — — 136.27K 19.18K — — — — — — — 21.63K — 20.45K —
Geode Capital Management — — — — — 14.36K 14.36K 14.36K 14.36K 14.36K 14.36K 14.36K 14.36K 14.36K 14.36K 14.36K 14.36K —
JANE STREET GROUP, LLC — — — — — 43.67K — — — — — — — — — — — —
Morgan Stanley — 2.51K — — — — — — — — — — — — — — — —
XTX Topco Ltd — — — — — — 25.59K — — — — — — — — — — —
HRT FINANCIAL LP — — — — — 16.83K — — — — — — — — — — — —
Bank of America Corp — — — — — 90 90 90 90 90 90 — — — — — — —
Two Sigma Investments — — — — — — — — — — — — — — — 45.88K — —

Download holders (CSV)

FAQ

Which funds hold NLSP?

16 funds have reported positions in NLSP across five years of 13F filings; the sum of their latest reported stakes is $1.23M.

Who are the top institutional holders of NLSP?

The largest 13F holders are ARMISTICE CAPITAL, LLC, BVF INC/IL, J. Goldman & Co LP, Affinity Asset Advisors, LLC, Two Sigma Investments; the top 25 are ranked at the top of this page.

Who are the major shareholders of NLS PHARMACEUTICS LTD?

The major shareholders of NLS PHARMACEUTICS LTD (NLSP) by reported 13F value are ARMISTICE CAPITAL, LLC, BVF INC/IL, J. Goldman & Co LP, Affinity Asset Advisors, LLC, Two Sigma Investments, among 16 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own NLSP" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/NLSP/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →